Loading...

BrainsWay Ltd.

BWAYNASDAQ
Healthcare
Medical - Devices
$11.73
$-0.11(-0.93%)

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 74.7/100

Key Financials

Market Cap221.7M
P/E Ratio55.27
EPS (TTM)$0.22
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Week$10.27
1 Month$10.11
3 Months$11.73
1 Year Target$15.21

BWAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BrainsWay Ltd. (BWAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.21.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 55.27 and a market capitalization of 221.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;